Study
group |
Age |
Males |
Females |
No.
of males and females. |
Total
% of males and females. |
HIV-TB |
< 20 |
2 |
0 |
2 |
4.88 |
|
20-40 |
10 |
2 |
12 |
29.27 |
|
Ø
40 |
6 |
2 |
8 |
19.5 |
Diabetes
-TB |
< 20 |
0 |
0 |
0 |
0 |
|
20-40 |
2 |
0 |
2 |
4.88 |
|
Ø
40 |
0 |
0 |
0 |
0 |
Immunocompetent
–TB |
< 20 |
2 |
1 |
3 |
7.31 |
|
20-40 |
6 |
2 |
8 |
19.51 |
|
Ø
40 |
4 |
2 |
6 |
14.63 |
Study Group |
Sputum Positive |
Sputum negative |
HIV positive(n=50) |
17(34%) |
33(66%) |
Diabetics (n=25) |
2(8%) |
23(92%) |
Immunocompetent(n=25) |
15(60%) |
10(40%) |
Total |
34 |
66 |
AFB Smear. |
HIV-positive Cases. |
Diabetics. |
Immunocompetent
persons. |
Negative |
33(66%) |
23(92%) |
10(40%) |
Scanty |
2(4%) |
0(0%) |
1(4%) |
1+ |
4(8%) |
1(4%) |
1(4%) |
2+ |
9(18%) |
1(4%) |
3(12%) |
3+ |
2(4%) |
0(0%) |
10(40%) |
Total |
50(50%) |
25(%) |
25(25%) |
|
Study
groups |
Culture
Positive
|
Culture
Negative |
Significant p-value |
1. |
HIV(n=50) |
|
|
0.0001 |
|
Smear positive |
17 |
0 |
|
|
Smear negative |
5 |
28 |
|
2. |
Diabetics(n=25) |
|
|
0.0033 |
|
Smear positive |
2 |
0 |
|
|
Smear negative |
0 |
23 |
|
3. |
Immunocompetent
(n=25) |
|
|
0.0008 |
|
Smear positive |
15 |
0 |
|
|
Smear negative |
2 |
8 |
|